Altimmune

ALT • NASDAQ • Stock Fundamentals

Altimmune is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Jerome Benedict Durso, with a market cap of $569.8M.

Market Cap$569.8M

Employees59.0

CEOJerome Benedict Durso

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 13, 2026 · 15 days agoQ1 2026

Next EarningsAug 11, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Altimmune

Altimmune (ALT) has a market capitalization of $569.8M and trades on NASDAQ.

Altimmune has approximately 59 employees.